2026 NPPES data Hematology & Oncology Physician NPI 1518979715 MD, PHD
Verify on CMS →

TOMISLAV DRAGOVICH, MD, PHD

Hematology & Oncology Physician in JACKSONVILLE, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
341
Medicare Part D claims · 88 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
81.4923/100
▼ 2 pts below national avg 83.1 · [object Object]
What the federal data reveals: TOMISLAV DRAGOVICH, MD, PHD is a Hematology & Oncology Physician ([object Object]) practicing in JACKSONVILLE, Florida with a Medicare Part D prescribing footprint of 341 claims across 88 beneficiaries — 18% brand-name prescribing . Their CMS MIPS Final Score of 81.4923/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities .

What the federal data shows

TOMISLAV DRAGOVICH, MD, PHD reported a CMS MIPS final score of 81.4923/100 — below the 83.1 national average — and filed 341 Medicare Part D claims in 2023.

81.4923/100
MIPS score · -2 vs avg
341
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TOMISLAV DRAGOVICH, MD, PHD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

81 36th percentile higher than 36% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

TOMISLAV DRAGOVICH, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

TOMISLAV DRAGOVICH, MD, PHD at a glance

Near national average

NPI registry status

Active

Issued 08/13/2006

NPI 1518979715

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

341 60% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

81.4923/100 1.6076999999999941% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Florida

How Hematology & Oncology Physician compares to other specialties among Florida providers

Florida providers

Hematology & Oncology Physician share within Florida

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Florida

Medicare quality performance — MIPS

TOMISLAV DRAGOVICH, MD, PHD's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Near national average
MIPS Final Score
81.4923/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 81.4923/100 vs national avg 83.1

0%100%National avg83%81.5%
MIPS final score (Hematology & Oncology Physician) — 81.4923/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TOMISLAV DRAGOVICH, MD, PHD is a Hematology & Oncology Physician provider practicing in JACKSONVILLE, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, PHD. NPI: 1518979715. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TOMISLAV DRAGOVICH, MD, PHD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD, PHD credentials at 1301 PALM AVE STE 700, JACKSONVILLE, FL, 32207, with a listed phone of (904) 202-7300. NPI 1518979715 was issued on 08/13/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DRAGOVICH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 341 prescription claims written by this provider, covering 88 Medicare beneficiaries and totaling roughly $217K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 8.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 81.4923/100 for the 2023 performance year, compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1301 PALM AVE STE 700
JACKSONVILLE, FL 32207

Provider Details

NPI 1518979715
Specialty Hematology & Oncology Physician
Credentials MD, PHD
Gender Male
NPI Issued 08/13/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

81.4923
Final Score
Avg: 83.1
38.3075
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where TOMISLAV DRAGOVICH, MD, PHD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BAPTIST MD ANDERSON CANCER PHYSICIANS INC
JACKSONVILLE, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to TOMISLAV DRAGOVICH, MD, PHD. To verify TOMISLAV DRAGOVICH, MD, PHD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

TOMISLAV DRAGOVICH, MD, PHD — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 341 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

341
Total Claims
$217K
Total Drug Cost
88
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
369
Total Day Supply
9,359
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$206K
Generic Drug Cost
$11K
Opioid Claims
29 (8.5% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
2.54
Gender Split
34% female / 66% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prochlorperazine Maleate
57
Ondansetron Hcl
47
Creon
Lipase/Protease/Amylase
23
Oxycodone Hcl
16
Lidocaine-Prilocaine
Lidocaine/Prilocaine
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How TOMISLAV DRAGOVICH, MD, PHD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

TOMISLAV DRAGOVICH, MD, PHD's 341 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as DRAGOVICH.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TOMISLAV DRAGOVICH, MD, PHD's specialty?
TOMISLAV DRAGOVICH, MD, PHD specializes in Hematology & Oncology Physician and practices in JACKSONVILLE, Florida. Credentials: MD, PHD.
How much does TOMISLAV DRAGOVICH, MD, PHD prescribe under Medicare Part D?
In 2023, TOMISLAV DRAGOVICH, MD, PHD wrote 341 Medicare Part D claims totaling $217K in drug costs for 88 beneficiaries.
What is TOMISLAV DRAGOVICH, MD, PHD's Medicare quality score?
TOMISLAV DRAGOVICH, MD, PHD has a CMS MIPS Final Score of 81.4923/100, Cost: 38.3075. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TOMISLAV DRAGOVICH, MD, PHD located?
TOMISLAV DRAGOVICH, MD, PHD is located at 1301 PALM AVE STE 700, JACKSONVILLE, FL, 32207. Phone: (904) 202-7300.
What is TOMISLAV DRAGOVICH, MD, PHD's NPI number?
TOMISLAV DRAGOVICH, MD, PHD's National Provider Identifier (NPI) is 1518979715, issued on 08/13/2006.
Does TOMISLAV DRAGOVICH, MD, PHD prescribe more brand-name or generic drugs?
TOMISLAV DRAGOVICH, MD, PHD's prescribing is 18% brand-name and 82% generic drugs by claim count, with $206K in brand drug costs.
Does TOMISLAV DRAGOVICH, MD, PHD prescribe opioids?
Yes, TOMISLAV DRAGOVICH, MD, PHD had 29 opioid claims in 2023 with an opioid prescribing rate of 8.5%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does TOMISLAV DRAGOVICH, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, TOMISLAV DRAGOVICH, MD, PHD's most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Hcl, Creon. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TOMISLAV DRAGOVICH, MD, PHD accept Medicare?
TOMISLAV DRAGOVICH, MD, PHD appears in CMS Medicare data with 341 Part D claims and 88 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TOMISLAV DRAGOVICH, MD, PHD's credentials?
TOMISLAV DRAGOVICH, MD, PHD's NPI is 1518979715 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology